Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and development.

The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

European companies must be able to provide developed and scalable business models if they want to enter the US to manage the ...

The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney ...

European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...

Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.

Teva Pharmaceutical has announced a collaboration with Fosun Pharma to advance the global development of the ATTENUKINE ...

After Biogen failed with a takeover bid in January, Supernus has swooped in to buy the postpartum depression pill developer.

Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.

Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.